News

All news

CSR Events General PERSONAL CARE Press release Products & Technologies Protéus

CELLforCURE launches a process to find a buyer for its Les Ulis site

CELLforCURE, a subsidiary of the SEQENS Group, has informed its employee representatives of its decision to look for a potential buyer for its site in Les Ulis (Essonne). CELLforCURE specializes in the development and the contract manufacturing of Cell & Gene therapies.

CELLforCURE by SEQENS to Manufacture Galapagos’ CAR T-Cell Therapy Candidates for Upcoming Trials

Key Visual SEQENS Personal Care Webinar

SEQENS Personal Care WEBINAR

CellProthera Selects CELLforCURE by SEQENS for Phase 3 GMP Manufacturing

Pascal Villemagne is SEQENS new CEO

SEQENS and Novonesis announce strategic partnership for enhancing customer’s access to industrial biocatalytic processes

SEQENS announces the appointement of a new CEO

SEQENS and APPLEXION announce strategic partnership for the distribution of SEQENZYM FT

SEQENS Personal Care Debuts AdvensProtect 8 Green Bio-based Caprylyl Glycol Multifunctional

SEQENS Personal Care launches Biobased Caprylyl Glycol for Make-up, Skin, and Hair Care Products

Personal Care and Homecare Ingredients (PCHi)

Smart Immune and CELLforCURE by SEQENS partner to industrialize SMART101 clinical batches manufacturing

Arkema Grants an Exclusive Technology License to SEQENS to manufacture PEKK

1 2 3 4 … 7

Contact